Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2015, Article ID 762128, 10 pages
http://dx.doi.org/10.1155/2015/762128
Review Article

Omics-Based Identification of Biomarkers for Nasopharyngeal Carcinoma

Department of Biochemistry, Faculty of Science, Mahidol University, Bangkok 10400, Thailand

Received 7 November 2014; Accepted 10 March 2015

Academic Editor: Lance A. Liotta

Copyright © 2015 Tavan Janvilisri. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. I. Wei and J. S. T. Sham, “Nasopharyngeal carcinoma,” The Lancet, vol. 365, no. 9476, pp. 2041–2054, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. E. T. Chang and H.-O. Adami, “The enigmatic epidemiology of nasopharyngeal carcinoma,” Cancer Epidemiology Biomarkers and Prevention, vol. 15, no. 10, pp. 1765–1777, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. S. H. Chan, “Aetiology of nasopharyngeal carcinoma,” Annals of the Academy of Medicine Singapore, vol. 19, no. 2, pp. 201–207, 1990. View at Google Scholar · View at Scopus
  4. Q. Tao and A. T. C. Chan, “Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments,” Expert Reviews in Molecular Medicine, vol. 9, no. 12, pp. 1–24, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. A. S. Chan, K. F. To, K. W. Lo et al., “High frequency of chromosome 3p deletion in histologically normal nasopharyngeal epithelia from Southern Chinese,” Cancer Research, vol. 60, no. 19, pp. 5365–5370, 2000. View at Google Scholar · View at Scopus
  6. J. T.-C. Chang, J.-Y. Ko, and R.-L. Hong, “Recent advances in the treatment of nasopharyngeal carcinoma,” Journal of the Formosan Medical Association, vol. 103, no. 7, pp. 496–510, 2004. View at Google Scholar · View at Scopus
  7. A. T. C. Chan, S. F. Leung, R. K. C. Ngan et al., “Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma,” Journal of the National Cancer Institute, vol. 97, no. 7, pp. 536–539, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. A. T. C. Chan, P. M. L. Teo, R. K. Ngan et al., “Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial,” Journal of Clinical Oncology, vol. 20, no. 8, pp. 2038–2044, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. A. R. A. Razak, L. L. Siu, F.-F. Liu, E. Ito, B. O'Sullivan, and K. Chan, “Nasopharyngeal carcinoma: the next challenges,” European Journal of Cancer, vol. 46, no. 11, pp. 1967–1978, 2010. View at Google Scholar · View at Scopus
  10. W. C.-S. Cho, “Nasopharyngeal carcinoma: molecular biomarker discovery and progress,” Molecular Cancer, vol. 6, article 1, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. Y.-J. Chen, J.-Y. Ko, P.-J. Chen et al., “Chromosomal aberrations in nasopharyngeal carcinoma analyzed by comparative genomic hybridization,” Genes, Chromosomes & Cancer, vol. 25, no. 2, pp. 169–175, 1999. View at Publisher · View at Google Scholar
  12. Y. Fang, X.-Y. Guan, Y. Guo et al., “Analysis of genetic alterations in primary nasopharyngeal carcinoma by comparative genomic hybridization,” Genes, Chromosomes & Cancer, vol. 30, no. 3, pp. 254–260, 2001. View at Publisher · View at Google Scholar
  13. G. Chien, P. W. Yuen, D. Kwong, and Y. L. Kwong, “Comparative genomic hybridization analysis of nasopharygeal carcinoma: consistent patterns of genetic aberrations and clinicopathological correlations,” Cancer Genetics and Cytogenetics, vol. 126, no. 1, pp. 63–67, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Yan, Y. Fang, Q. Liang, Y. Huang, and Y. Zeng, “Novel chromosomal alterations detected in primary nasopharyngeal carcinoma by comparative genomic hybridization,” Chinese Medical Journal, vol. 114, no. 4, pp. 418–421, 2001. View at Google Scholar · View at Scopus
  15. S. Rodriguez, A. Khabir, C. Keryer et al., “Conventional and array-based comparative genomic hybridization analysis of nasopharyngeal carcinomas from the Mediterranean area,” Cancer Genetics and Cytogenetics, vol. 157, no. 2, pp. 140–147, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Shih-Hsin Wu, “Construction of evolutionary tree models for nasopharyngeal carcinoma using comparative genomic hybridization data,” Cancer Genetics and Cytogenetics, vol. 168, no. 2, pp. 105–108, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. B. A. Bejjani, A. P. Theisen, B. C. Ballif, and L. G. Shaffer, “Array-based comparative genomic hybridization in clinical diagnosis,” Expert Review of Molecular Diagnostics, vol. 5, no. 3, pp. 421–429, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Wang and Q. Cheng, “Microarray analysis in drug discovery and clinical applications,” Methods in Molecular Biology, vol. 316, pp. 49–65, 2006. View at Google Scholar · View at Scopus
  19. A. B.-Y. Hui, K.-W. Lo, P. M. L. Teo, K.-F. To, and D. P. Huang, “Genome wide detection of oncogene amplifications in nasopharyngeal carcinoma by array based comparative genomic hybridization,” International Journal of Oncology, vol. 20, no. 3, pp. 467–473, 2002. View at Google Scholar · View at Scopus
  20. X. Guo, W.-O. Lui, C.-N. Qian et al., “Identifying cancer-related genes in nasopharyngeal carcinoma cell lines using DNA and mRNA expression profiling analyses,” International Journal of Oncology, vol. 21, no. 6, pp. 1197–1204, 2002. View at Google Scholar · View at Scopus
  21. Y. Y. Or, A. B. Y. Hui, K. Y. Tam, D. P. Huang, and K. W. Lo, “Characterization of chromosome 3q and 12q amplicons in nasopharyngeal carcinoma cell lines,” International journal of oncology, vol. 26, no. 1, pp. 49–56, 2005. View at Google Scholar · View at Scopus
  22. C. Hu, W. Wei, X. Chen et al., “A global view of the oncogenic landscape in nasopharyngeal carcinoma: an integrated analysis at the genetic and expression levels,” PLoS ONE, vol. 7, no. 7, Article ID e41055, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. X. Zhang, W. Li, H. Li, Y. Ma, G. He, and G. Tan, “Genomic methylation profiling combined with gene expression microarray reveals the aberrant methylation mechanism involved in nasopharyngeal carcinoma taxol resistance,” Anti-Cancer Drugs, vol. 23, no. 8, pp. 856–864, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. X. L. Yang, C. D. Zhang, H. Y. Wu et al., “Effect of trichostatin A on CNE2 nasopharyngeal carcinoma cells—genome-wide DNA methylation alteration,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 11, pp. 4663–4670, 2014. View at Publisher · View at Google Scholar
  25. D. C. Lin, X. Meng, M. Hazawa et al., “The genomic landscape of nasopharyngeal carcinoma,” Nature Genetics, vol. 46, no. 8, pp. 866–871, 2014. View at Google Scholar
  26. W. Tulalamba, N. Larbcharoensub, and T. Janvilisri, “ERBB3 as an independent prognostic marker for nasopharyngeal carcinoma,” Journal of Clinical Pathology, vol. 67, no. 8, pp. 667–672, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Bucca, G. Carruba, A. Saetta, P. Muti, L. Castagnetta, and C. P. Smith, “Gene expression profiling of human cancers,” Annals of the New York Academy of Sciences, vol. 1028, pp. 28–37, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. O. D. von Stein, “Isolation of differentially expressed genes through subtractive suppression hybridization,” Methods in Molecular Biology, vol. 175, pp. 263–278, 2001. View at Google Scholar · View at Scopus
  29. B.-C. Zhang, L. Cao, J. Qian et al., “Construction of directional cDNA library from human embryo nasopharyngeal epithelia and screeming a candidate tumor suppressor gene related with nasopharyngeal carcinoma,” Progress in Biochemistry and Biophysics, vol. 29, no. 2, pp. 302–306, 2002. View at Google Scholar · View at Scopus
  30. B. C. Zhang, X. M. Nie, B. Y. Xiao et al., “Identification of tissue-specific genes in nasopharyngeal epithelial tissue and differentially expressed genes in nasopharyngeal carcinoma by suppression subtractive hybridization and cDNA microarray,” Genes Chromosomes and Cancer, vol. 38, no. 1, pp. 80–90, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Zhou, Z. Zeng, W. Zhang et al., “Identification of candidate molecular markers of nasopharyngeal carcinoma by microarray analysis of subtracted cDNA libraries constructed by suppression subtractive hybridization,” European Journal of Cancer Prevention, vol. 17, no. 6, pp. 561–571, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Schena, R. A. Heller, T. P. Theriault, K. Konrad, E. Lachenmeier, and R. W. Davis, “Microarrays: biotechnology's discovery platform for functional genomics,” Trends in Biotechnology, vol. 16, no. 7, pp. 301–306, 1998. View at Publisher · View at Google Scholar · View at Scopus
  33. Y.-C. G. Lee, Y.-C. Hwang, K.-C. Chen et al., “Effect of Epstein-Barr virus infection on global gene expression in nasopharyngeal carcinoma,” Functional & Integrative Genomics, vol. 7, no. 1, pp. 79–93, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. V. Sriuranpong, A. Mutirangura, J. W. Gillespie et al., “Global gene expression profile of nasopharyngeal carcinoma by laser capture microdissection and complementary DNA microarrays,” Clinical Cancer Research, vol. 10, no. 15, pp. 4944–4958, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. Z. Y. Zeng, Y. H. Zhou, W. Xiong et al., “Analysis of gene expression identifies candidate molecular markers in nasopharyngeal carcinoma using microdissection and cDNA microarray,” Journal of Cancer Research and Clinical Oncology, vol. 133, no. 2, pp. 71–81, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. Z.-Q. Liu, Y.-Q. Tian, Y.-F. Hu, X.-L. Li, F.-R. Ma, and G.-Y. Li, “Alteration of gene expression during nasopharyngeal carcinogenesis revealed by oligonucleotide microarray after microdissection of tumor tissue and normal epithelia from nasopharynx,” Chinese Medical Journal (Engl), vol. 122, no. 4, pp. 437–443, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. W. Zhang, Z. Zeng, Y. Zhou et al., “Identification of aberrant cell cycle regulation in Epstein-Barr virus-associated nasopharyngeal carcinoma by cDNA microarray and gene set enrichment analysis,” Acta Biochimica et Biophysica Sinica, vol. 41, no. 5, Article ID gmp025, pp. 414–428, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. Z. Y. Zeng, Y. H. Zhou, W. L. Zhang et al., “Gene expression profiling of nasopharyngeal carcinoma reveals the abnormally regulated Wnt signaling pathway,” Human Pathology, vol. 38, no. 1, pp. 120–133, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Li, Y. Fan, J. Chen, K.-T. Yao, and Z.-X. Huang, “Microarray analysis of differentially expressed genes between nasopharyngeal carcinoma cell lines 5–8F and 6–10B,” Cancer Genetics and Cytogenetics, vol. 196, no. 1, pp. 23.e1–23.e13, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. B. Su, H.-L. Tang, M. Deng et al., “Stage-associated dynamic activity profile of transcription factors in nasopharyngeal carcinoma progression based on protein/DNA array analysis,” OMICS, vol. 15, no. 1-2, pp. 49–60, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Wang, X. Li, Z. G. Li et al., “Gene expression profile changes and possible molecular subtypes in differentiated-type nonkeratinizing nasopharyngeal carcinoma,” International Journal of Cancer, vol. 128, no. 4, pp. 753–762, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Marguerat and J. Bähler, “RNA-seq: from technology to biology,” Cellular and Molecular Life Sciences, vol. 67, no. 4, pp. 569–579, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. C. Y.-Y. Szeto, C. H. Lin, S. C. Choi et al., “Integrated mRNA and microRNA transcriptome sequencing characterizes sequence variants and mRNA-microRNA regulatory network in nasopharyngeal carcinoma model systems,” FEBS Open Bio, vol. 4, pp. 128–140, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. D. R. Rhodes and A. M. Chinnaiyan, “Integrative analysis of the cancer transcriptome,” Nature Genetics, vol. 37, no. 6, pp. S31–S37, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. W.-C. Cheng, M.-L. Tsai, C.-W. Chang et al., “Microarray meta-analysis database (M2DB): a uniformly pre-processed, quality controlled, and manually curated human clinical microarray database,” BMC Bioinformatics, vol. 11, article 421, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. X. Chen, S. Liang, W. L. Zheng, Z. J. Liao, T. Shang, and W. L. Ma, “Meta-analysis of nasopharyngeal carcinoma microarray data explores mechanism of EBV-regulated neoplastic transformation,” BMC Genomics, vol. 9, article 322, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. M. T. McManus, “MicroRNAs and cancer,” Seminars in Cancer Biology, vol. 13, no. 4, pp. 253–258, 2003. View at Publisher · View at Google Scholar · View at Scopus
  48. D. P. Bartel, “MicroRNAs: genomics, biogenesis, mechanism, and function,” Cell, vol. 116, no. 2, pp. 281–297, 2004. View at Publisher · View at Google Scholar · View at Scopus
  49. D. P. Bartel, “MicroRNAs: target recognition and regulatory functions,” Cell, vol. 136, no. 2, pp. 215–233, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. G. A. Calin and C. M. Croce, “MicroRNA signatures in human cancers,” Nature Reviews Cancer, vol. 6, no. 11, pp. 857–866, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. G. Li, Y. Qiu, Z. Su et al., “Genome-wide analyses of radioresistance-associated miRNA expression profile in nasopharyngeal carcinoma using next generation deep sequencing,” PLoS ONE, vol. 8, no. 12, Article ID e84486, 2013. View at Publisher · View at Google Scholar · View at Scopus
  52. G. Li, Y. Liu, Z. Su et al., “MicroRNA-324-3p regulates nasopharyngeal carcinoma radioresistance by directly targeting WNT2B,” European Journal of Cancer, vol. 49, no. 11, pp. 2596–2607, 2013. View at Google Scholar · View at Scopus
  53. N. Liu, N.-Y. Chen, R.-X. Cui et al., “Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis,” The Lancet Oncology, vol. 13, no. 6, pp. 633–641, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. H.-Y. Wang, L.-X. Yan, Q. Shao et al., “Profiling plasma microRNA in nasopharyngeal carcinoma with deep sequencing,” Clinical Chemistry, vol. 60, no. 5, pp. 773–782, 2014. View at Publisher · View at Google Scholar · View at Scopus
  55. Y. Iwadate, “Clinical proteomics in cancer research-promises and limitations of current two-dimensional Gel electrophoresis,” Current Medicinal Chemistry, vol. 15, no. 23, pp. 2393–2400, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. W. H. McDonald and J. R. Yates III, “Shotgun proteomics and biomarker discovery,” Disease Markers, vol. 18, no. 2, pp. 99–105, 2002. View at Publisher · View at Google Scholar · View at Scopus
  57. P. Jiang, M. Gan, H. Huang, X. Shen, S. Wang, and K. Yao, “Proteome analysis of antiproliferative mechanism of 12-O-tetradecanoylphorbol 13-acetate on cultured nasopharyngeal carcinoma CNE2 cells,” Journal of Proteome Research, vol. 4, no. 2, pp. 599–605, 2005. View at Publisher · View at Google Scholar · View at Scopus
  58. P.-Z. Jiang, M. Gan, H. Huang, X.-M. Shen, S. Wang, and K.-T. Yao, “Proteomics-based identification of proteins with altered expression induced by 12-O-tetradecanoylphorbol 13-acetate in nasopharyngeal carcinoma CNE2 cells,” Acta Biochimica et Biophysica Sinica, vol. 37, no. 2, pp. 97–106, 2005. View at Publisher · View at Google Scholar · View at Scopus
  59. C. M. L. Chan, S. C. C. Wong, M. Y. Y. Lam et al., “Proteomic comparison of nasopharyngeal cancer cell lines C666-1 and NP69 identifies down-regulation of annexin II and β2-tubulin for nasopharyngeal carcinoma,” Archives of Pathology and Laboratory Medicine, vol. 132, no. 4, pp. 675–683, 2008. View at Google Scholar · View at Scopus
  60. X.-P. Feng, H. Yi, M.-Y. Li et al., “Identification of biomarkers for predicting nasopharyngeal carcinoma response to radiotherapy by proteomics,” Cancer Research, vol. 70, no. 9, pp. 3450–3462, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. L. Li, S. Huang, X. Zhu et al., “Identification of radioresistance-associated proteins in human nasopharyngeal carcinoma cell lines by proteomic analysis,” Cancer Biotherapy & Radiopharmaceuticals, vol. 28, no. 5, pp. 380–384, 2013. View at Publisher · View at Google Scholar · View at Scopus
  62. B. Zhang, J.-Q. Qu, L. Xiao et al., “Identification of heat shock protein 27 as a radioresistance-related protein in nasopharyngeal carcinoma cells,” Journal of Cancer Research and Clinical Oncology, vol. 138, no. 12, pp. 2117–2125, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. G.-P. Li, H. Wang, Y.-K. Lai et al., “Proteomic profiling between CNE-2 and its strongly metastatic subclone S-18 and functional characterization of HSP27 in metastasis of nasopharyngeal carcinoma,” Proteomics, vol. 11, no. 14, pp. 2911–2920, 2011. View at Publisher · View at Google Scholar · View at Scopus
  64. X. Feng, J. Zhang, W. N. Chen, and C. B. Ching, “Proteome profiling of Epstein-Barr virus infected nasopharyngeal carcinoma cell line: identification of potential biomarkers by comparative iTRAQ-coupled 2D LC/MS-MS analysis,” Journal of Proteomics, vol. 74, no. 4, pp. 567–576, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. H. Xue, B. Lu, and M. Lai, “The cancer secretome: a reservoir of biomarkers,” Journal of Translational Medicine, vol. 6, article 52, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. C.-C. Wu, K.-Y. Chien, N.-M. Tsang et al., “Cancer cell-secreted proteomes as a basis for searching potential tumor markers: nasopharyngeal carcinoma as a model,” Proteomics, vol. 5, no. 12, pp. 3173–3182, 2005. View at Publisher · View at Google Scholar · View at Scopus
  67. S. Ge, Y. Mao, Y. Yi, D. Xie, Z. Chen, and Z. Xiao, “Comparative proteomic analysis of secreted proteins from nasopharyngeal carcinoma-associated stromal fibroblasts and normal fibroblasts,” Experimental and Therapeutic Medicine, vol. 3, no. 5, pp. 857–860, 2012. View at Publisher · View at Google Scholar · View at Scopus
  68. S.-J. Lin, K.-P. Chang, C.-W. Hsu et al., “Low-molecular-mass secretome profiling identifies C-C motif chemokine 5 as a potential plasma biomarker and therapeutic target for nasopharyngeal carcinoma,” Journal of Proteomics, vol. 94, pp. 186–201, 2013. View at Publisher · View at Google Scholar · View at Scopus
  69. Y.-H. Chang, C.-C. Wu, K.-P. Chang, J.-S. Yu, Y.-C. Chang, and P.-C. Liao, “Cell secretome analysis using hollow fiber culture system leads to the discovery of CLIC1 protein as a novel plasma marker for nasopharyngeal carcinoma,” Journal of Proteome Research, vol. 8, no. 12, pp. 5465–5474, 2009. View at Publisher · View at Google Scholar · View at Scopus
  70. H.-Y. Wu, Y.-H. Chang, Y.-C. Chang, and P.-C. Liao, “Proteomics analysis of nasopharyngeal carcinoma cell secretome using a hollow fiber culture system and mass spectrometry,” Journal of Proteome Research, vol. 8, no. 1, pp. 380–389, 2009. View at Publisher · View at Google Scholar · View at Scopus
  71. Y. Chen, G.-L. Ouyang, H. Yi et al., “Identification of RKIP as an invasion suppressor protein in nasopharyngeal carcinoma by proteomic analysis,” Journal of Proteome Research, vol. 7, no. 12, pp. 5254–5262, 2008. View at Publisher · View at Google Scholar · View at Scopus
  72. Y. Chen, C.-E. Tang, G.-L. Ouyang et al., “Identification of RKIP as a differentially tyrosine-phosphorylated protein in nasopharyngeal carcinoma and normal nasopharyngeal epithelial tissues by phosphoproteomic approach,” Medical Oncology, vol. 26, no. 4, pp. 463–470, 2009. View at Publisher · View at Google Scholar · View at Scopus
  73. A.-L. Cheng, W.-G. Huang, Z.-C. Chen et al., “Identification of novel nasopharyngeal carcinoma biomarkers by laser capture microdissection and proteomic analysis,” Clinical Cancer Research, vol. 14, no. 2, pp. 435–445, 2008. View at Publisher · View at Google Scholar · View at Scopus
  74. A.-L. Cheng, W.-G. Huang, Z.-C. Chen et al., “Identificating cathepsin d as a biomarker for differentiation and prognosis of nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis,” Journal of Proteome Research, vol. 7, no. 6, pp. 2415–2426, 2008. View at Publisher · View at Google Scholar · View at Scopus
  75. Z. Xiao, G. Li, Y. Chen et al., “Quantitative proteomic analysis of formalin-fixed and paraffin-embedded nasopharyngeal carcinoma using iTRAQ labeling, two-dimensional liquid chromatography, and tandem mass spectrometry,” Journal of Histochemistry and Cytochemistry, vol. 58, no. 6, pp. 517–527, 2010. View at Publisher · View at Google Scholar · View at Scopus
  76. X.-M. Li, W.-G. Huang, H. Yi, A.-L. Cheng, and Z.-Q. Xiao, “Proteomic analysis to identify cytokeratin 18 as a novel biomarker of nasopharyngeal carcinoma,” Journal of Cancer Research and Clinical Oncology, vol. 135, no. 12, pp. 1763–1775, 2009. View at Publisher · View at Google Scholar · View at Scopus
  77. M.-X. Li, Z.-Q. Xiao, Y.-F. Liu et al., “Quantitative proteomic analysis of differential proteins in the stroma of nasopharyngeal carcinoma and normal nasopharyngeal epithelial tissue,” Journal of Cellular Biochemistry, vol. 106, no. 4, pp. 570–579, 2009. View at Publisher · View at Google Scholar · View at Scopus
  78. M. Li, C. Li, D. Li et al., “Periostin, a stroma-associated protein, correlates with tumor invasiveness and progression in nasopharyngeal carcinoma,” Clinical & Experimental Metastasis, vol. 29, no. 8, pp. 865–877, 2012. View at Publisher · View at Google Scholar · View at Scopus
  79. C.-E. Tang, T. Tan, C. Li et al., “Identification of Galectin-1 as a novel biomarker in nasopharyngeal carcinoma by proteomic analysis,” Oncology Reports, vol. 24, no. 2, pp. 495–500, 2010. View at Publisher · View at Google Scholar · View at Scopus
  80. W. C. S. Cho, T. T. C. Yip, C. Yip et al., “Identification of serum amyloid a protein as a potentially useful biomarker to monitor relapse of nasopharyngeal cancer by serum proteomic profiling,” Clinical Cancer Research, vol. 10, no. 1, part 1, pp. 43–52, 2004. View at Publisher · View at Google Scholar · View at Scopus
  81. P.-H. Peng, C.-C. Wu, S.-C. Liu et al., “Quantitative plasma proteome analysis reveals aberrant level of blood coagulation-related proteins in nasopharyngeal carcinoma,” Journal of Proteomics, vol. 74, no. 5, pp. 744–757, 2011. View at Publisher · View at Google Scholar · View at Scopus
  82. Y.-L. Tao, Y. Li, J. Gao et al., “Identifying FGA peptides as nasopharyngeal carcinoma-associated biomarkers by magnetic beads,” Journal of Cellular Biochemistry, vol. 113, no. 7, pp. 2268–2278, 2012. View at Publisher · View at Google Scholar · View at Scopus
  83. Y.-S. Wei, Y.-H. Zheng, W.-B. Liang et al., “Identification of serum biomarkers for nasopharyngeal carcinoma by proteomic analysis,” Cancer, vol. 112, no. 3, pp. 544–551, 2008. View at Publisher · View at Google Scholar · View at Scopus
  84. Y.-J. Huang, C. Xuan, B.-B. Zhang et al., “SELDI-TOF MS profiling of serum for detection of nasopharyngeal carcinoma,” Journal of Experimental and Clinical Cancer Research, vol. 28, article 85, 2009. View at Publisher · View at Google Scholar · View at Scopus
  85. S.-M. Cao, J.-K. Yu, Q.-Y. Chen et al., “Detection of nasopharyngeal carcinoma using surface-enhanced laser desorption and ionization mass spectrometry profiles of the serum proteome,” Chinese Journal of Cancer, vol. 29, no. 8, pp. 721–728, 2010. View at Publisher · View at Google Scholar · View at Scopus
  86. F. Su, X. Zhu, Z. Liang et al., “Analysis of serum proteome profiles in nasopharyngeal carcinoma with different radiosensitivity,” Clinical and Translational Oncology, vol. 16, no. 2, pp. 147–152, 2014. View at Publisher · View at Google Scholar · View at Scopus
  87. L. Ruan, X.-H. Li, X.-X. Wan et al., “Analysis of EGFR signaling pathway in nasopharyngeal carcinoma cells by quantitative phosphoproteomics,” Proteome Science, vol. 9, article 35, 2011. View at Publisher · View at Google Scholar · View at Scopus
  88. J. Liu, X. Zhan, M. Li et al., “Mitochondrial proteomics of nasopharyngeal carcinoma metastasis,” BMC Medical Genomics, vol. 5, article 62, 2012. View at Publisher · View at Google Scholar · View at Scopus
  89. C. J. Clarke and J. N. Haselden, “Metabolic profiling as a tool for understanding mechanisms of toxicity,” Toxicologic Pathology, vol. 36, no. 1, pp. 140–147, 2008. View at Publisher · View at Google Scholar · View at Scopus
  90. G. A. N. Gowda, S. Zhang, H. Gu, V. Asiago, N. Shanaiah, and D. Raftery, “Metabolomics-based methods for early disease diagnostics,” Expert Review of Molecular Diagnostics, vol. 8, no. 5, pp. 617–633, 2008. View at Publisher · View at Google Scholar · View at Scopus
  91. L. Yi, N. Dong, S. Shi et al., “Metabolomic identification of novel biomarkers of nasopharyngeal carcinoma,” RSC Advances, vol. 4, no. 103, pp. 59094–59101, 2014. View at Publisher · View at Google Scholar
  92. L. Yi, C. Song, Z. Hu et al., “A metabolic discrimination model for nasopharyngeal carcinoma and its potential role in the therapeutic evaluation of radiotherapy,” Metabolomics, vol. 10, no. 4, pp. 697–708, 2014. View at Publisher · View at Google Scholar · View at Scopus